Skip to main content
logo
Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.2479
+0.0479 (23.95%)
Sep 30, 2026, 9:30 AM EST

Guided Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2447108158
Market Cap Growth
19.28%376.20%17.63%-43.03%84.30%101.40%
Enterprise Value
275015131817
Last Close Price
0.250.540.150.150.300.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
36.8260.661395.6684.751121.4497.66
PB Ratio
-4.15-7.75-2.00-2.18-5.06-1.45

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
42.1965.812134.23129.381364.13210.72

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.48-0.49-0.44-0.51-0.78-0.53
Net Debt / Equity Ratio
-0.48-0.48-0.36-0.360.02-0.41
Net Debt / EBITDA Ratio
-1.41-1.22-0.84-0.500.02-0.96
Net Debt / FCF Ratio
-1.84-2.69-1.58-0.780.03-1.40
Asset Turnover
0.610.570.010.040.010.05
Inventory Turnover
0.290.360.010.110.140.10
Quick Ratio
0.000.010.060.120.480.12
Current Ratio
0.090.090.190.290.620.29
Return on Assets (ROA)
-115.63%-109.73%-86.48%-67.47%-77.07%-87.09%
Return on Capital Employed (ROCE)
39.70%44.70%44.10%86.60%221.80%64.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.23%-6.87%-24.74%-42.01%-29.78%-26.17%
FCF Yield
-6.29%-2.30%-11.45%-21.02%-10.36%-20.30%
Buyback Yield / Dilution
-32.38%-36.75%-12.14%-57.30%-142.99%-24.24%